C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab vs. Placebo Post Surgery and Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma

被引：0

作者：

Rischin, D. ^{[1
]}

Brungs, D. ^{[2
]}

Day, F. ^{[3
]}

Christie, H. ^{[4
]}

Patel, V. A. ^{[5
]}

Adams, G. ^{[6
]}

Jackson, J. E. ^{[7
]}

Schurmann, M. D. L. V. ^{[8
]}

Kirtbaya, D. ^{[9
]}

Shin, T. M. ^{[10
]}

Hart, C. D. ^{[11
]}

Stankevich, E. ^{[12
]}

Li, S. ^{[13
]}

Lowy, I. ^{[13
]}

Han, H. ^{[13
]}

Fury, M. G. ^{[13
]}

Porceddu, S. ^{[14
]}

机构：

[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[2] Wollongong Hosp, Illawarra Canc Care Ctr, Wollongong, NSW, Australia

[3] Calvary Mater Newcastle, Dept Med Oncol, Waratah, Australia

[4] Canc Care Ctr Hervey Bay, Urraween, Australia

[5] George Washington Univ, Sch Med & Hlth Sci, Inst Patient Ctr Initiat & Hlth Equ, Washington, DC USA

[6] Genesis Canc Care, Bundaberg, Qld, Australia

[7] Radiat Oncol Ctr, Gold Coast, Australia

[8] Univ Planalto Catarinense UNIPLAC, Animi Oncol Treatment Unit, Lages, SC, Brazil

[9] State Budgetary Inst Hlth Oncol Dispensary 2, Krasnodar, Russia

[10] Hosp Univ Penn, Dept Dermatol, Perelman Ctr Adv Med, Philadelphia, PA USA

[11] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia

[12] Regeneron Pharmaceut, Tarrytown, NY USA

[13] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[14] Princess Alexandra Hosp, Dept Radiat Oncol, Woolloongabba, Qld, Australia

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3372

引用

页码：E610 / E611

页数：2